Eton Pharmaceuticals (ETON) Other Non-Current Assets (2017 - 2026)
Eton Pharmaceuticals (ETON) posted Other Non-Current Assets of $19000.0 for Q4 2025, little changed sequentially from $19000.0 in Q3 2025, and up 58.33% YoY from $12000.0 in Q4 2024.
Eton Pharmaceuticals (ETON) Other Non-Current Assets (2017 - 2026) Analysis & Trends
Eton Pharmaceuticals has reported Other Non-Current Assets for 9 years, with the latest figure at $19000.0 in Q4 2025.
- Quarterly Other Non-Current Assets rose 58.33% year-over-year to $19000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $19000.0 (up 58.33% YoY) and the FY2025 annual result came in at $19000.0, up 58.33% from the prior year.
- Other Non-Current Assets steadied at $19000.0 in Q4 2025 per ETON's latest filing, from $19000.0 in the prior quarter.
- Over five years, Other Non-Current Assets peaked at $36000.0 in Q1 2021 and troughed at $12000.0 in Q1 2022.
- A 5-year average of $15900.0 and a median of $12000.0 in 2022 frame the typical range for Other Non-Current Assets.
- The sharpest annual moves came in 2021 and 2025: Other Non-Current Assets sank 71.6% in 2021, then surged 58.33% in 2025.
- Over 5 years, Other Non-Current Assets stood at $21000.0 in 2021, then plunged by 42.86% to $12000.0 in 2022, then changed by 0.0% to $12000.0 in 2023, then changed by 0.0% to $12000.0 in 2024, then soared by 58.33% to $19000.0 in 2025.
- According to Business Quant data, Other Non-Current Assets over the past three periods registered $19000.0, $19000.0, and $12000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.94 Bn | 42.97 Bn | - | 56.35 Mn |
| 2 | Teva Pharmaceutical Industries | 43.08 Bn | 39.43 Bn | 2.15 Bn | 1.79 Bn |
| 3 | Zoetis | 31.54 Bn | 29.87 Bn | 1.05 Bn | 384.00 Mn |
| 4 | Takeda Pharmaceutical | 28.60 Bn | 22.80 Bn | 5.10 Bn | 503.80 Mn |
| 5 | United Therapeutics | 22.12 Bn | 19.46 Bn | 683.80 Mn | 239.50 Mn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | 1.06 Bn |
| 7 | Neurocrine Biosciences | 15.50 Bn | 15.11 Bn | 935.80 Mn | 59.30 Mn |
| 8 | Elanco Animal Health | 11.69 Bn | 11.16 Bn | 798.00 Mn | 304.00 Mn |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.96 Bn | - | 13.00 Mn |
| 10 | Eton Pharmaceuticals | 1.67 Bn | 1.64 Bn | 25.41 Mn | 64,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 64,000.00 |
| Dec 31, 2025 | 19,000.00 |
| Sep 30, 2025 | 19,000.00 |
| Jun 30, 2025 | 12,000.00 |
| Mar 31, 2025 | 12,000.00 |
| Dec 31, 2024 | 12,000.00 |
| Sep 30, 2024 | 12,000.00 |
| Jun 30, 2024 | 12,000.00 |
| Mar 31, 2024 | 12,000.00 |
| Dec 31, 2023 | 12,000.00 |
| Sep 30, 2023 | 12,000.00 |
| Jun 30, 2023 | 12,000.00 |
| Mar 31, 2023 | 12,000.00 |
| Dec 31, 2022 | 12,000.00 |
| Sep 30, 2022 | 12,000.00 |
| Jun 30, 2022 | 12,000.00 |
| Mar 31, 2022 | 12,000.00 |
| Dec 31, 2021 | 21,000.00 |
| Sep 30, 2021 | 23,000.00 |
| Jun 30, 2021 | 32,000.00 |